Vivimed

News across the web »
Interact & exchange stock tips & market info »

khakra

Platinum Member

958 Followers

Related News »
Vivimed Labs may touch Rs 600, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities. Bandyopadhyay told CNBC-Awaaz, "One can invest in Vivimed Labs with a long term view. The stock is getting on low valuation; we can see level of Rs 600 in ...
May 25, 2012 at 10:27 | Source: MoneyControl.com
A meeting of the Board of Directors of Vivimed Labs Ltd will be held on May 30, 2012, to consider the Audited Financial Results for financial year ended March 31, 2012 and to consider recommendation of final dividend for financial year ended March 31, 2012.
May 17, 2012 at 12:24 | Source: equitybulls.com
Its key clients include New Silk Route PE, Godrej Properties, Vodafone India, Vivimed Labs, ICICI Securities, BNP Paribas, Credit Suisse and Deutsche Bank, among others. It also advised Indian OTA MakeMyTrip on its $80.5 million NASDAQ IPO.
May 28, 2012 at 11:49 | Source: vccircle.com